Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $2.1 million.

  • BioScience Health Innovations' Liabilities and Shareholders Equity rose 39710.22% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 62848.42%. This contributed to the annual value of $873788.0 for FY2024, which is 83565.34% up from last year.
  • Per BioScience Health Innovations' latest filing, its Liabilities and Shareholders Equity stood at $2.1 million for Q3 2025, which was up 39710.22% from $2.1 million recorded in Q2 2025.
  • BioScience Health Innovations' Liabilities and Shareholders Equity's 5-year high stood at $2.1 million during Q3 2025, with a 5-year trough of $374.0 in Q2 2021.
  • Over the past 5 years, BioScience Health Innovations' median Liabilities and Shareholders Equity value was $93388.0 (recorded in 2023), while the average stood at $405343.9.
  • In the last 5 years, BioScience Health Innovations' Liabilities and Shareholders Equity crashed by 9836.5% in 2021 and then soared by 643903.74% in 2022.
  • Over the past 5 years, BioScience Health Innovations' Liabilities and Shareholders Equity (Quarter) stood at $96134.0 in 2021, then crashed by 70.52% to $28343.0 in 2022, then soared by 229.49% to $93388.0 in 2023, then skyrocketed by 835.65% to $873788.0 in 2024, then surged by 136.57% to $2.1 million in 2025.
  • Its Liabilities and Shareholders Equity was $2.1 million in Q3 2025, compared to $2.1 million in Q2 2025 and $1.4 million in Q1 2025.